| 12202836 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Mark Edward Bunnage, Seungil Han, David Hepworth +18 more |
2025-01-21 |
|
| 12129256 |
Pyrazolo[1,5-a]pyrazin-4-yl derivatives |
Matthew Frank Brown, Alpay Dermenci, Andrew Fensome, Brian Stephen Gerstenberger, Matthew Merrill Hayward +3 more |
2024-10-29 |
$505,385,000 |
| 12064398 |
Parenteral formulations |
Jitinder WILKHU |
2024-08-20 |
|
| 11980648 |
Compositions including ginsenoside 20(S)-Rg3 and methods of using ginsenoside 20(S)-Rg3 to inhibit alpha herpesvirus |
Shannon Smith, Karen Maynard, Elliot Altman |
2024-05-14 |
|
| 11702424 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Mark Edward Bunnage, Seungil Han, David Hepworth +18 more |
2023-07-18 |
$390,606,000 |
| 11472809 |
Pyrazolo[1,5-a]pyrazin-4-yl derivatives |
Matthew Frank Brown, Alpay Dermenci, Andrew Fensome, Brian Stephen Gerstenberger, Matthew Merrill Hayward +3 more |
2022-10-18 |
$393,425,000 |
| 11426362 |
Oral cannabinoid formulations |
Jitinder WILKHU |
2022-08-30 |
|
| 11254668 |
Pyrazolo[1,5-A]pyrazin-4-yl and related derivatives |
Brian Stephen Gerstenberger, Andrew Fensome, Dafydd Rhys Owen, Matthew Frank Brown, Matthew Merrill Hayward +2 more |
2022-02-22 |
$482,573,000 |
| 11229612 |
Parenteral formulations |
Jitinder WILKHU |
2022-01-25 |
|
| 10906888 |
Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme |
Agustin Casimiro-Garcia, Joseph Walter Strohbach, David Hepworth, Frank Eldridge Lovering, Chulho Choi +1 more |
2021-02-02 |
$640,415,000 |
| 10822341 |
Pyrazolo[1,5-a]pyrazin-4-yl derivatives |
Matthew Frank Brown, Alpay Dermenci, Andrew Fensome, Brian Stephen Gerstenberger, Matthew Merrill Hayward +3 more |
2020-11-03 |
$385,583,000 |
| 10793579 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Mark Edward Bunnage, Seungil Han, David Hepworth +18 more |
2020-10-06 |
$629,973,000 |
| 10329302 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Mark Edward Bunnage, Seungil Han, David Hepworth +18 more |
2019-06-25 |
$317,230,000 |
| 10316018 |
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators |
Katherine Lin Lee, Christophe Philippe Allais, Christoph Martin Dehnhardt, Lori Krim Gavrin, Seungil Han +10 more |
2019-06-11 |
$297,650,000 |
| 10174000 |
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators |
Katherine Lin Lee, Christophe Philippe Allais, Christoph Martin Dehnhardt, Lori Krim Gavrin, Seungil Han +10 more |
2019-01-08 |
$262,548,000 |
| 10144738 |
Pyrazolo[1,5-A]PYRAZIN-4-YL derivatives |
Matthew Frank Brown, Alpay Dermenci, Andrew Fensome, Brian Stephen Gerstenberger, Matthew Merrill Hayward +3 more |
2018-12-04 |
$489,814,000 |
| 9879022 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Mark Edward Bunnage, Seungil Han, David Hepworth +18 more |
2018-01-30 |
$267,454,000 |
| 9458168 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Mark Edward Bunnage, Seungil Han, David Hepworth +15 more |
2016-10-04 |
$808,860,000 |
| 6291489 |
Process for substituted pyridines |
Keith M. DeVries, Robert L. Dow |
2001-09-18 |
$792,266,000 |
| 5843972 |
Heterocyclic .beta.-adrenergic agonists |
Robert L. Dow |
1998-12-01 |
$267,380,000 |
| 5767133 |
Secondary amines as antidiabetic and antiobesity agents |
Robert L. Dow |
1998-06-16 |
$353,705,000 |
| 5110831 |
Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors |
Ronald L. Magolda |
1992-05-05 |
$9,782,000 |
| 5049570 |
Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity |
Douglas G. Batt |
1991-09-17 |
$11,168,000 |
